187 related articles for article (PubMed ID: 15845858)
21. Variability in Expression of CYP3A5 in Human Fetal Liver.
Vyhlidal CA; Pearce RE; Gaedigk R; Calamia JC; Shuster DL; Thummel KE; Leeder JS
Drug Metab Dispos; 2015 Aug; 43(8):1286-93. PubMed ID: 25979262
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing midazolam hydroxylation activity in human liver microsomes.
He P; Court MH; Greenblatt DJ; von Moltke LL
Drug Metab Dispos; 2006 Jul; 34(7):1198-207. PubMed ID: 16638818
[TBL] [Abstract][Full Text] [Related]
23. Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle.
Sarkar MA; Vadlamuri V; Ghosh S; Glover DD
Drug Metab Dispos; 2003 Jan; 31(1):1-6. PubMed ID: 12485945
[TBL] [Abstract][Full Text] [Related]
24. The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture.
Greuet J; Pichard L; Bonfils C; Domergue J; Maurel P
Biochem Biophys Res Commun; 1996 Aug; 225(2):689-94. PubMed ID: 8753820
[TBL] [Abstract][Full Text] [Related]
25. Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors.
Betts S; Björkhem-Bergman L; Rane A; Ekström L
Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):261-6. PubMed ID: 25689036
[TBL] [Abstract][Full Text] [Related]
26. Catalysis of the 4-hydroxylation of retinoic acids by cyp3a7 in human fetal hepatic tissues.
Chen H; Fantel AG; Juchau MR
Drug Metab Dispos; 2000 Sep; 28(9):1051-7. PubMed ID: 10950848
[TBL] [Abstract][Full Text] [Related]
27. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.
Schuetz JD; Beach DL; Guzelian PS
Pharmacogenetics; 1994 Feb; 4(1):11-20. PubMed ID: 8004129
[TBL] [Abstract][Full Text] [Related]
28. Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression.
Vyhlidal CA; Gaedigk R; Leeder JS
Drug Metab Dispos; 2006 Jan; 34(1):131-7. PubMed ID: 16243958
[TBL] [Abstract][Full Text] [Related]
29. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
[TBL] [Abstract][Full Text] [Related]
30. Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression.
Sy SK; Ciaccia A; Li W; Roberts EA; Okey A; Kalow W; Tang BK
Eur J Clin Pharmacol; 2002 Aug; 58(5):357-65. PubMed ID: 12185560
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the Stimulatory and Inhibitory Effects of Steroid Hormones and α-Naphthoflavone on Steroid Hormone Hydroxylation Catalyzed by Human Cytochrome P450 3A Subfamilies.
Niwa T; Toyota M; Kawasaki H; Ishii R; Sasaki S
Biol Pharm Bull; 2021; 44(4):579-584. PubMed ID: 33790108
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory anti-CYP3A4 peptide antibody: mapping of inhibitory epitope and specificity toward other CYP3A isoforms.
Wang RW; Newton DJ; Liu NY; Shou M; Rushmore T; Lu AY
Drug Metab Dispos; 1999 Feb; 27(2):167-72. PubMed ID: 9929498
[TBL] [Abstract][Full Text] [Related]
33. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
Burk O; Tegude H; Koch I; Hustert E; Wolbold R; Glaeser H; Klein K; Fromm MF; Nuessler AK; Neuhaus P; Zanger UM; Eichelbaum M; Wojnowski L
J Biol Chem; 2002 Jul; 277(27):24280-8. PubMed ID: 11940601
[TBL] [Abstract][Full Text] [Related]
35. Efficient complementary DNA directed expression of human fetal liver cytochrome P450 (CYP3A7) in insect cells using baculovirus.
Sakuma T; Kitamura R; Yokoi T; Kamataki T
Biochem Mol Biol Int; 1995 Feb; 35(2):447-55. PubMed ID: 7663401
[TBL] [Abstract][Full Text] [Related]
36. A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels.
Smit P; van Schaik RH; van der Werf M; van den Beld AW; Koper JW; Lindemans J; Pols HA; Brinkmann AO; de Jong FH; Lamberts SW
J Clin Endocrinol Metab; 2005 Sep; 90(9):5313-6. PubMed ID: 15985487
[TBL] [Abstract][Full Text] [Related]
37. CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids.
Nakamura H; Torimoto N; Ishii I; Ariyoshi N; Nakasa H; Ohmori S; Kitada M
Drug Metab Dispos; 2003 Apr; 31(4):432-8. PubMed ID: 12642469
[TBL] [Abstract][Full Text] [Related]
38. Human cytochrome P450 3A7 has a distinct high catalytic activity for the 16alpha-hydroxylation of estrone but not 17beta-estradiol.
Lee AJ; Conney AH; Zhu BT
Cancer Res; 2003 Oct; 63(19):6532-6. PubMed ID: 14559847
[TBL] [Abstract][Full Text] [Related]
39. Human Fetal Liver Metabolism of Oxycodone Is Mediated by CYP3A7.
Shum S; Isoherranen N
AAPS J; 2021 Jan; 23(1):24. PubMed ID: 33438174
[TBL] [Abstract][Full Text] [Related]
40. Expression and regulation of human fetal-specific CYP3A7 in mice.
Pang XY; Cheng J; Kim JH; Matsubara T; Krausz KW; Gonzalez FJ
Endocrinology; 2012 Mar; 153(3):1453-63. PubMed ID: 22253426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]